Jun Tao1, Han-Zhu Qian, Aaron M Kipp, Yuhua Ruan, Bryan E Shepherd, Kathy Rivet Amico, Yiming Shao, Hongyan Lu, Sten H Vermund. 1. aVanderbilt Institute for Global Health bDivision of Epidemiology, Departments of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA cState Key Laboratory of Infectious Disease Prevention and Control (SKLID), Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Chinese Center for Disease Control and Prevention (China CDC), Beijing, China dDepartments of Biostatistics, Vanderbilt University School of Medicine, Nashville, Tennessee, USA eDepartment of Health Behavior and Health Education, University of Michigan, Ann Arbor, Michigan, USA fBeijing Center for Disease Control and Prevention, Beijing, China gDepartment of Pediatrics, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
Abstract
OBJECTIVE: Our objective was to explore the effect of depression and anxiety on adherence to antiretroviral therapy (ART) among MSM with newly diagnosed HIV infections. DESIGN: We conducted a prospective study of Chinese MSM with newly diagnosed HIV infections. METHODS: The Hospital Anxiety and Depression Scale was used to measure depression and anxiety at baseline, 6 and 12 months, separately. ART adherence was self-reported once every 3 months ('perfect' or no missing dose in the past 3 months vs. 'imperfect' adherence or at least one missing dose in the past 3 months). We utilized a priori substantial knowledge guided by causal models to identify confounding covariates, and performed mixed-effect logistic regression to assess the effects of depression and anxiety on ART adherence. RESULTS: We included 228 participants who initiated ART after HIV diagnosis and before the end of study. A one-unit increase in the depression and anxiety score was associated with a 16% increase [adjusted odds ratio (aOR), 1.16; 95% confidence interval (CI), 1.02-1.32] and a 17% increase (aOR, 1.17; 95% CI, 1.03-1.33) in the odds of reporting imperfect ART adherence, respectively. When depression and anxiety were categorized (normal, borderline, and likely), only likely anxiety had a significant association with imperfect ART adherence (aOR, 4.79; 95% CI, 1.12-20.50). CONCLUSION:Depression and anxiety are risk factors for imperfect ART adherence among Chinese MSM with newly diagnosed HIV infections. Intensive intervention on depression and/or anxiety beyond regular post-HIV-testing counseling may increase adherence to ART, and improve HIV treatment outcomes.
RCT Entities:
OBJECTIVE: Our objective was to explore the effect of depression and anxiety on adherence to antiretroviral therapy (ART) among MSM with newly diagnosed HIV infections. DESIGN: We conducted a prospective study of Chinese MSM with newly diagnosed HIV infections. METHODS: The Hospital Anxiety and Depression Scale was used to measure depression and anxiety at baseline, 6 and 12 months, separately. ART adherence was self-reported once every 3 months ('perfect' or no missing dose in the past 3 months vs. 'imperfect' adherence or at least one missing dose in the past 3 months). We utilized a priori substantial knowledge guided by causal models to identify confounding covariates, and performed mixed-effect logistic regression to assess the effects of depression and anxiety on ART adherence. RESULTS: We included 228 participants who initiated ART after HIV diagnosis and before the end of study. A one-unit increase in the depression and anxiety score was associated with a 16% increase [adjusted odds ratio (aOR), 1.16; 95% confidence interval (CI), 1.02-1.32] and a 17% increase (aOR, 1.17; 95% CI, 1.03-1.33) in the odds of reporting imperfect ART adherence, respectively. When depression and anxiety were categorized (normal, borderline, and likely), only likely anxiety had a significant association with imperfect ART adherence (aOR, 4.79; 95% CI, 1.12-20.50). CONCLUSION:Depression and anxiety are risk factors for imperfect ART adherence among Chinese MSM with newly diagnosed HIV infections. Intensive intervention on depression and/or anxiety beyond regular post-HIV-testing counseling may increase adherence to ART, and improve HIV treatment outcomes.
Authors: Claudia Siqueira Tufano; Ricardo Abrantes do Amaral; Luciana Roberta Donola Cardoso; André Malbergier Journal: Sao Paulo Med J Date: 2014-09-19 Impact factor: 1.044
Authors: Wayne T Steward; Gregory M Herek; Jayashree Ramakrishna; Shalini Bharat; Sara Chandy; Judith Wrubel; Maria L Ekstrand Journal: Soc Sci Med Date: 2008-07-01 Impact factor: 4.634
Authors: Jun Tao; Yuhua Ruan; Lu Yin; Sten H Vermund; Bryan E Shepherd; Yiming Shao; Han-Zhu Qian Journal: AIDS Patient Care STDS Date: 2013-08-09 Impact factor: 5.078
Authors: Ajay K Sethi; David D Celentano; Stephen J Gange; Richard D Moore; Joel E Gallant Journal: Clin Infect Dis Date: 2003-09-19 Impact factor: 9.079
Authors: Zachary L Mannes; Larry E Burrell; Eugene M Dunne; Lauren E Hearn; Nicole Ennis Whitehead Journal: J Assoc Nurses AIDS Care Date: 2016-11-28 Impact factor: 1.354
Authors: Ryan P Coyle; Christopher D Schneck; Mary Morrow; Stacey S Coleman; Edward M Gardner; Jia-Hua Zheng; Lucas Ellison; Lane R Bushman; Jennifer J Kiser; Samantha Mawhinney; Peter L Anderson; Jose R Castillo-Mancilla Journal: AIDS Behav Date: 2019-12
Authors: Dirk A Davis; Kathryn E Muessig; Derrick D Matthews; Gustavo Angeles; Luz McNaughton-Reyes; Karla Guzmán; Sanny Northbrook; Clare Barrington Journal: Health Promot Int Date: 2021-11-28 Impact factor: 3.734
Authors: Yu Liu; Sten H Vermund; Yuhua Ruan; Hongjie Liu; K Rivet Amico; Jane M Simoni; Bryan E Shepherd; Yiming Shao; Han-Zhu Qian Journal: J Int AIDS Soc Date: 2018-02 Impact factor: 5.396
Authors: D Wei; X Wang; X You; X Luo; C Hao; J Gu; S Peng; X Yang; Y Hao; Vincent M B Silenzio; J Li; F Hou Journal: Epidemiol Psychiatr Sci Date: 2020-06-15 Impact factor: 6.892